Ladiratuzumab vedotin, CAS [[1629760-29-7]]

Product Overview

• Article Name: Ladiratuzumab vedotin, CAS [[1629760-29-7]]
• Biozol Catalog Number: MCE-HY-P99683
• Supplier Catalog Number: HY-P99683
• Alternative Catalog Number: MCE-HY-P99683-10MG,MCE-HY-P99683-1MG,MCE-HY-P99683-5MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: SGN-LIV1A

Product Description

Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC50: 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer[1][2][3][4].

Product Properties

• Purity: 99.80
• CAS Number: [1629760-29-7]
• Target: Antibody-Drug Conjugates (ADCs)

Application Notes

• Application Notes: ADC Related